The FDA, under the guidance of Robert F. Kennedy Jr., is changing its approach to seasonal COVID-19 vaccine approvals, limiting access to individuals aged 65 and over or those with specific health risks. This decision, articulated by FDA Commissioner Martin Makary and vaccine regulator Vinay Prasad, bypasses traditional review processes by advisory committees, leading to a new framework for vaccine distribution that has raised concerns among public health experts.
Makary and Prasad argue in the NEJM that previous universal access to COVID-19 vaccines was "patronizing to Americans," framing the new approach as more tailored and respectful.
They assert that the previous policy represented a "one-size-fits-all" approach, suggesting that a more selective vaccination strategy acknowledges individual circumstances.
Collection
[
|
...
]